Introduction
Metabolic syndrome (MetS) consists of a clustering of cardiometabolic risk factors, including abdominal obesity, glucose intolerance, insulin resistance, atherogenic dyslipidemia, and hypertension 1) . The syndrome is closely associated with the development of type 2 diabetes and atherosclerotic cardiovascular disease 2) . Of the various risk factors listed above, central obesity and insulin resistance are considered the most important 3) .The pathophysiology underlying MetS is nonetheless complex and multifactorial. Current evidence favors the proposal that mitochondrial dysfunction contributes to abnormal oxidative stress with the initiation and development of atherosclerosis, cardiovascular disease, aging, and insulin resistance 4) . In our previous report, alteration of the leukocyte mtDNA copy number can reflect the oxidative stress of plasma in a normal healthy population 5) . Thus, we suspected Abbreviations; MetS: metabolic syndrome, mtDNA: mitochondrial DNA, SBP: systolic blood pressure, DBP: diastolic blood pressure, TG: triglycerides, HDL-C: HDL-cholesterol, LDL-C: LDL-cholesterol that alteration of the leukocyte, not tissue, mtDNA copy number may also serve as a surrogate of oxidative stress to predict the severity of MetS, the pathogenesis of which also results from oxidative stress. The present study was undertaken to ascertain whether the leukocyte mtDNA copy number is altered in subjects with the syndrome and, if so, whether the alterations correlate with the presence of other cardiometabolic risk factors.
Materials and Methods

Subjects
Initially, 200 subjects were recruited from Changhua Christian Hospital, Changhua, Taiwan during 2003-2004. This group consisted of 100 non-MetS subjects and 100 subjects with MetS under the design of sex and age matched method. Informed consent for enrolment in the study was obtained from each subject, and the ethics standards of Changhua Christian Hospital were followed throughout the course of the study. MetS was defined as the presence of three or more of the clinical criteria established by the NCEP ATP with modification 6, 7) . Non-MetS was defined as the presence of less than two or none of the clinical criteria of the NCEP ATP with modification. Specifically, abdominal obesity was defined as a waist circumference ≥ 90 cm in men and ≥ 80 cm in women according to the International Obesity Task Force criteria for central obesity in Asians. High blood pressure was defined as systolic blood pressure ≥ 130 mmHg and diastolic blood pressure ≥ 85 mmHg and /or currently taking medication for hypertension. Hypertriglyceridemia was defined as a serum value ≥ 150 mg/ dL. Low HDL-cholesterol was defined as a serum value 40 mg/dL in men and 50 mg/dL in women. Hyperglycemia was defined as a fasting blood glucose concentration ≥ 100 mg/dL and/or current use of insulin or oral medication for diabetes. Subjects taking vitamin supplements or statins were excluded. No limitations or lifestyle changes were experienced by any subject during the course of the study. The history of smoking was obtained by questionnaire. Finally, 80 non-MetS subjects and 50 subjects with MetS were included in this study.
Biochemical Measurements
Total serum cholesterol was determined enzymatically using the Sigma Diagnostics cholesterol reagent (Sigma Chemical Co., St. Louis, MO). Serum HDL-cholesterol (HDL-C) was determined using the Sigma Diagnostics HDL-C reagent and formulated according to the recommendations of Warnick et al. 8) .
Dextran sulfate and magnesium ions were used for precipitation and isolation of LDL and VLDL particles. Serum triglyceride (TG) concentrations were determined using the Sigma Diagnostics TG reagent and the modification described by McGowan et al. 9) . LDLcholesterol (LDL-C) concentration was calculated according to the formula developed by Friedewald et al. 10) . Serum insulin concentrations were measured using commercially available enzyme-linked immunosorbent assay kits (R&D Systems) in accordance with the manufacturer's instructions.
Determination of the MtDNA Copy Number of Human Leukocytes
Total leukocyte DNA from buffy coat was extracted by the Gentra Puregene DNA kit (Qiagen, Gemany), avoiding platelet contamination. Leukocyte mtDNA copy number was assessed using a LightCycler Instrument (Roche, Mannheim, Germany) and the procedure described in our previous report 5) . Briefly, PCR was performed by amplification of the ND1 gene in mtDNA and the -globin gene in nuclear DNA from sampled DNA, and calculation of the mtDNA copy number was interpolated from the linearity of the dosage-dependently constructed standard plasmid of the ND1/ -globin gene.
Statistical Analyses
All statistical procedures were performed using the SPSS statistical software package (v15.0; SPSS, Chicago, IL). All findings are expressed as the means with standard deviations. Differences between two groups of subjects were evaluated using Student's t-test; P values 0.05 were significant. A partial correlation with age, smoking and gender control was used to evaluate associations between metabolic factors and mtDNA copy number. Trend analysis was applied to compare the numbers of MetS criteria. Multiple co-variant ANOVA was applied to compare normal and abnormal HDL/blood pressure.
Results
No significant difference in the proportion of the leukocyte subpopulation was found by Levene homogeneity test of variance (data not shown). Table 1 presents the demographic, biochemical, and clinical characteristics of the study subjects. Subjects in the MetS group displayed expected anthropometric and metabolic alternations associated with MetS, including increased waist circumference, elevated blood pressure, increased glucose, insulin, creatinine, and triglyceride concentrations, and decreased HDL-cholesterol concentration ( p 0.05); differences in these parameters between the two groups were statistically significant. Additionally, the mtDNA copy number for subjects in the MetS group was lower than that for nonMetS subjects; the difference between the two groups was significant ( p 0.05).
Age and sex were reported as two confounding factors related to alteration of the mtDNA copy number 5, 11) .Then we applied the partial correlation to process the analysis in Table 2 under age and sex control. MtDNA copy number of leukocytes from subjects with MetS was found to correlate positively with the HDL-cholesterol concentration and negatively with blood pressure, HOMA-IR and triglyceride concentration; however, the mtDNA copy number was not significantly correlated with waist circumference, smoking index, fasting glucose, insulin, BUN, creatinine, total cholesterol, or LDL-cholesterol concentration.
The relationship between the leukocyte mtDNA copy number and number of components of MetS for all subjects enrolled in this study is shown in Fig. 1 .
The components examined were those established by the NCEP ATP and included abdominal obesity, hypertriglyceridemia, hypertension, low HDL concentration, and high fasting glucose concentration. MetS was defined as the presence of three or more components of the syndrome as established by the NCEP ATP . The mean mtDNA copy number was found to decrease as the number of components of MetS increased ( p 0.05).
Mean mtDNA copy numbers for the study population according to low and normal HDL-cholesterol values are presented in Fig. 2 . Copy numbers for subjects with low HDL-cholesterol values were significantly lower than those with normal HDL-cholesterol values ( p 0.05).
Mean mtDNA copy numbers for the study population according to normal and high systolic or diastolic blood pressure are shown in Fig. 3 . Copy numbers of mtDNA were significantly lower for subjects with high blood pressure as compared to those with normal blood pressure ( p 0.05). 
Discussion
The possibility that mtDNA copy number serves as a surrogate marker of mitochondrial function was previously proposed on the basis of the observed close association between the mtDNA copy number and several cardiovascular risk factors, including insulin resistance, aging, abdominal obesity, prevalence of microalbuminuria, and cancer risk 12) . The present study is the first to determine the mtDNA copy number for subjects with and without MetS. The leukocyte mtD-NA copy number was found to decrease as the number of diagnostic components of MetS increased. Similar reductions in the mtDNA copy number were reported for human immunodeficiency virus patients who were treated with nucleoside reverse transcriptase inhibitors and developed type 2 diabetes 13) . Similarly, increased mtDNA copy number via the over-expression of mitochondrial transcription factor A is proposed to serve in the defence of myocytes against cardiac failure 14) and of neurons against age-dependent memory impairment 15) . Thus, maintenance of a relatively high mtDNA copy number therefore appears to represent a physiologic process designed for tissue protection.
A lower serum level of HDL is one major criterion in the prediction of MetS. The decrease in HDLcholesterol values observed in these MetS patients also coincided with the depleted mtDNA copy number, which was consistent with our previous studies 16) especially in healthy subjects with a high level of LDL. Low HDL-cholesterol is a negative prognostic factor of cardiovascular outcome and is strongly predictive of coronary heart disease, even in subjects with a desirable total cholesterol 17) . Exercise also increases the leukocyte mtDNA copy number and HDL level, which may improve insulin sensitivity 18) . In light of these considerations, the novel correlation between the leukocyte mtDNA copy number and HDL-cholesterol observed in the present study underscores the impact of atherogenic lipids in MetS.
A high level of serum triglyceride has also been identified as a major factor in the prediction of MetS. In an in vivo study, Aflaki et al. disclosed a particular pathway related to intracellular triglyceride accumulation that promoted mitochondrial dysfunction with the consequence of programmed cell death in macrophages 19) . Aronis et al. stated that exposure to TG provoked down-regulation in mtDNA genomic biogenesis, including Peroxisome proliferator-activated receptor-gamma coactivator-1alpha and nuclear respiratory factor -1, two critical transcription factors to maintain the required mtDNA content 20) . In the present study, a significant negative correlation between the leukocyte mtDNA copy number and serum triglyceride concentration implicated a similar phenomenon in the relationship between triglyceride metabolism and the regulation of mitochondrial copy number in leukocytes.
Insulin resistance and hyperinsulinemia may induce the depleted mtDNA copy number in adipose tissue 21) . Alteration of the copy number in mtDNA was recently applied in the investigation of common diseases, including diabetes 22) . MtDNA damage can be easily found in diabetic retinopathy and over-expression of manganese superoxide dismutase can ameliorate damage to the mitochondrial genome in diabetes 23) . MtDNA copy number in peripheral blood monocytes has a significant positive relationship with the onset of type 2 diabetes and the severity of diabetic complications; however, not in the siblings of diabetic patients 24, 25) . Lee et al. reported that depleted mtDNA copies were disclosed in diabetes patients, showing an especially negative correlation to the waisthip circumference ratio, fasting glucose level and diastolic blood pressure. Depletion of the mtDNA copy number of leukocytes also correlates with the incidence of diabetes and is possibly related to the nutrition status of the fetus 26, 27) . In our study, we also found a similar result that a higher plasma level of fasting blood sugar and higher value of HOMA-IR were accompanied with lower leukocyte mtDNA content in correlation analysis under adjustment for age ( Table 2 ). This evidence indicates higher relevance between the leukocyte mtDNA content and insulin resistance.
In the Framingham study, the mitochondrial genomic background is related to the status of the blood pressure of siblings 28) . In a study of a Chinese population, some risk mtDNA genes with putative functional changes in rRNA genes and tRNA genes were disclosed to be related to the incidence of hypertension 29, 30) . In hypertensive individuals, circulating leucocytes exhibited a higher level of hydrogen peroxide and greater mitochondrial membrane potential than the normotensive group 31) . In our study, metabolic syndrome with hypertension revealed a lower mtDNA copy number in leukocytes, imply that the physiological change of vascular pressure also reflects the entity of hypertension through the mechanism of maintaining adequate genomes of mtDNA.
However, we still found a limitation of the present study that our reference data failed to reveal the relationship between the mtDNA copy number and the insulin/LDL level, which implied that an unknown mechanism is involved in the pathogenesis of MetS other than the mtDNA alteration.
In conclusion, the peripheral blood leukocyte mtDNA copy number is a novel marker of MetS, reflecting the burden of the components of the syndrome. The extent to which the mtDNA copy number is decreased may reveal the severity of MetS. The mtDNA copy number has a robust correlation with HDL-cholesterol, triglyceride, and blood pressure. In the future, we will examine the alteration of the mtD-NA copy number in a subpopulation of leukocytes (e.g. lymphocytes or neutrophils). We will also elucidate the pathogenesis of MetS related to the bioenergetic pathway, especially in mtDNA replication/ fusion/fission, not only in leukocytes but also in other tissues, e.g. muscle or pancreas.
